Anesthetic Regimen Assessment for Intubation in Patients with Cardiovascular Disease

Medication Dosage Analysis

The American Society of Anesthesiologists recommends a Rocuronium dose of 1.0-1.2 mg/kg for rapid sequence intubation, which is higher than the current dose of 40 mg (0.8 mg/kg) for a 50 kg patient 1
For patients with cardiovascular disease, the recommended Ketamine dose is 1-2 mg/kg IV, which is higher than the current dose of 30 mg (0.6 mg/kg) for a 50 kg patient 1, 2
The Midazolam dose of 2 mg is within the recommended range of 2-5 mg for induction, and the Fentanyl dose of 100 mcg is at the lower end of the recommended range for suppressing laryngeal reflexes during intubation 3

The American Society of Anesthesiologists suggests that hemodynamic stability is crucial during induction and intubation in patients with cardiovascular disease and poor reserve 3, 4
Ketamine provides relative hemodynamic stability through its sympathomimetic effects, which is beneficial in patients with cardiovascular compromise 2

The American Society of Anesthesiologists recommends administering Rocuronium at 1.0-1.2 mg/kg to ensure optimal intubating conditions for rapid sequence intubation 3, 1
Insufficient neuromuscular blockade increases the risk of coughing, bucking, and hemodynamic instability during intubation, which is particularly dangerous in a patient with poor cardiovascular reserve 3

Increasing the Rocuronium dose to at least 50 mg (1.0 mg/kg) is recommended to ensure adequate muscle paralysis for intubation 1
Consider increasing the Ketamine dose to 50 mg (1.0 mg/kg) to provide better hemodynamic stability, especially given the patient's cardiovascular disease 1, 2

Patients with cardiovascular disease may have depleted catecholamine stores, potentially limiting Ketamine's sympathomimetic effects and increasing the risk of hypotension 2
Ensure vasopressors are immediately available to manage potential hypotension during induction 1